Newton, MA, United States of America

Lazlo Varady

This inventor holds 1 USPTO granted patent. Top assignee: Microdose Therapeutx, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lazlo Varady. Retrieved from https://idiyas.com/inventor/lazlo-varady

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lazlo Varady: Innovator in Nucleoside Tetraphosphate Analog Research

Introduction

Lazlo Varady is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of nucleoside tetraphosphate analogs. His work has the potential to impact medical treatments for various disorders.

Latest Patents

Lazlo Varady holds 1 patent for his invention titled "Methods of making nucleoside tetraphosphate analogs." This invention provides compounds and methods for creating adenosine-ribofuranoside tetraphosphate compounds. These compounds are believed to have activity at the P2Y receptor and may be utilized in treating medical disorders such as cystic fibrosis and upper respiratory disorders.

Career Highlights

Varady is currently associated with Microdose Therapeutx, Inc., where he continues to advance his research and development efforts. His innovative approach to biochemistry has positioned him as a key figure in his field.

Collaborations

Lazlo has worked alongside talented colleagues, including Carmen M Baldino and Dan P Cook. Their collaborative efforts contribute to the ongoing success of their projects and research initiatives.

Conclusion

Lazlo Varady's work in nucleoside tetraphosphate analogs showcases his dedication to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…